Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Hepatitis C and HIV Co-infection


Date: Oct 25, 2022 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Nov 01, 2022 10:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Physicians
  • Nurse Practitioners
  • Physician Assistants

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Clinical Pharmacy Associates

 

 

Registration Closed  

Objectives

  • Describe the impact of HCV on HIV-infected patients that includes highlighting the goal of HCV therapy
  • Outline the USPHS medication treatment options for HCV in HIV infected patients
  • Explain the DC ADAP formulary option for the treatment of Hepatitis C
  • Identify key components of the DC ADAP prior authorization program for HCV treatment

Speaker(s)/Author(s)

Pierre Ndje, Pharm.D., Pharm.D.
PGY1 Pharmacy Resident, Veterans Affair Medical Center

Activity Number

0010-9999-22-064-L02-P
Date: 10/25/22
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed